Edition:
India

Master Pharm SA (MPH.WA)

MPH.WA on Warsaw Stock Exchange

5.00PLN
21 Feb 2020
Change (% chg)

0.00zł (+0.00%)
Prev Close
5.00zł
Open
5.00zł
Day's High
5.00zł
Day's Low
5.00zł
Volume
1,168
Avg. Vol
6,466
52-wk High
6.10zł
52-wk Low
4.02zł

Latest Key Developments (Source: Significant Developments)

Master Pharm Supervisory Board Approves Sale Of Unit Avet Pharma
Monday, 23 Dec 2019 

Dec 23 (Reuters) - Master Pharm SA ::SUPERVISORY BOARD APPROVES SALE OF ITS UNIT AVET PHARMA.  Full Article

Master Pharm FY Revenue At 74.6 Million Zlotys
Thursday, 18 Apr 2019 

April 18 (Reuters) - Master Pharm SA ::FY REVENUE 74.6 MILLION ZLOTYS VERSUS PREVIOUSLY ESTIMATED 74.8 MILLION ZLOTYS.FY NET PROFIT 10.7 MILLION ZLOTYS VERSUS PREVIOUSLY ESTIMATED 11 MILLION ZLOTYS.  Full Article

Master Pharm Estimates 2018 Net Profit At 10.96 Million Zlotys
Thursday, 31 Jan 2019 

Jan 31 (Reuters) - Master Pharm SA ::ESTIMATES 2018 NET PROFIT AT 10.96 MILLION ZLOTYS, UP 24% VERSUS YEAR AGO.ESTIMATES 2018 REVENUES AT 74.81 MILLION ZLOTYS, UP 15% VERSUS YEAR AGO.  Full Article

Master Pharm Signs Confidentiality Agreement With Potential Investor
Thursday, 29 Nov 2018 

Nov 30 (Reuters) - MASTER PHARM SA ::SAID ON THURSDAY THAT IT HAS SIGNED A CONFIDENTIALITY AGREEMENT WITH A POTENTIAL INVESTOR FROM THE SAME INDUSTRY .AS A PART OF THE AGREEMENT THE POTENTIAL INVESTOR TO START DUE DILLIGENCE ON CO.ON NOV. 21 CO INFORMED ABOUT ITS PLANS TO TO REVISE STRATEGIC OPTIONS nFWN1XW0XE.  Full Article

Master Pharm Q1 Net Profit Up At 3.0 Mln Zlotys
Monday, 14 May 2018 

May 15 (Reuters) - MASTER PHARM SA ::REPORTED ON MONDAY Q1 NET PROFIT OF 3.0 MILLION ZLOTYS VERSUS 1.6 MILLION ZLOTYS YEAR AGO.Q1 REVENUE 17.8 MILLION ZLOTYS VERSUS 13.3 MILLION ZLOTYS YEAR AGO.Q1 EBITDA 4.2 MILLION ZLOTYS VERSUS 2.6 MILLION ZLOTYS YEAR AGO .  Full Article

Master Pharm Plans FY 2017 Dividend Of 0.26 Zloty/Shr
Saturday, 14 Apr 2018 

April 16 (Reuters) - Master Pharm SA ::SAID ON FRIDAY MANAGEMENT HAS PROPOSED FY 2017 DIVIDEND OF 0.26 ZLOTY PER SHARE .  Full Article